사이트 메뉴
NKCL Classic
NK Cell
Project
About Project
White Paper
News
EN
CN
KR
Roadmap
Roadmap
Videos
Videos
FAQ
FAQ
News
Personalized Immune Cell Treatment NKCL Classic
EN
CN
KR
GK Global Group Co., Ltd. and G-ASSET are newly participating as Venture Capital of NKCL Bio Group.
NKCL
2022.04.25 18:32
GK Global Group Co., Ltd. and G-ASSET are newly participating as Venture Capital of NKCL Bio Group.
Attach Files
1414.png
List